Injective News and DeFi Protocol Insights

8.53
0.05
0.60 %
Daily range
Weekly range
  • Viktoras Karapetjanc
  • 13 hours ago
INJ slides more than 10% as heavy selling hits despite ETF proposals and solid protocol metrics
Injective (INJ) fell 10.17% today as heavy intraday selling pressure outweighed recent positive protocol and governance developments. The decline is reinforced by the asset testing the lower end ...
  • Aleksandra Chaikina
  • 16.10.2026
INJ climbs more than 29% after institutional partnerships and SEC-registered status
Injective (INJ) spiked 29.07% after securing key regulatory milestones, with institutional partnerships and an SEC-registered transfer agent status increasing investor demand. The surge is ...
  • Sholanke Dele
  • 16.10.2026
Injective upward price move as institutional interest and strong volumes support rally
Injective (INJ) is trading at $9.25 after climbing 27.57% over the past day, with the move keeping the asset above its key moving ...
  • Ivan Andriyenko
  • 15.10.2026
Injective falls amid sustained selling pressure
Injective (INJ) is trading at $7.28, down 8.93% on the day after a volatile session that saw the asset open with a notable $0.32 gap. The price currently sits below its ...
  • Ashutosh Sureka
  • 15.10.2026
Injective drops more than 12% after SEC transfer agent status and ETF applications in focus
Injective (INJ) fell 12.26% following elevated volatility, even as the platform recorded several notable institutional and regulatory developments. The decline is supported by short-term selling ...
  • Viktoras Karapetjanc
  • 14.10.2026
INJ drops as downward price momentum intensifies
Injective (INJ) is trading at $7.71, down 7.6% on the day, with the move taking it below its short- and medium-term moving averages but still holding above key long-term ...
  • Oleg Tkachenko
  • 14.10.2026
Injective rises nearly 10% as SEC approval and real-world asset expansion boost market momentum
Injective (INJ) surged 9.88% after becoming an SEC-registered transfer agent and expanding its real-world asset capabilities, drawing fresh institutional and regulatory momentum into the market. ...
  • Sholanke Dele
  • 13.10.2026
Injective gains SEC approval for transfer agent status: INJ gains momentum
Injective (INJ) is trading at $8.15 after climbing 7.07% on the day, with price action situated above its key moving averages and close to today's intraday high. ...
  • Anastasiia Chabaniuk
  • 13.10.2026
INJ weekly outlook: Can the move above all major averages fuel further upside?
Injective (INJ) is holding near $8 after rising over 5% this past week as institutional activity drives momentum. Updates around ETF filings and new tokenization ...
  • Oleg Tkachenko
  • 11.10.2026
Injective technical analysis: Rally challenges $8.15 resistance
Injective (INJ) is trading at $7.72, gaining 8.67% on the day. The price sits above its key moving averages, reflecting continued strength in the current ...
  • Jainam Mehta
  • 10.10.2026
Injective rises over 10% as derivatives activity surges and community buybacks fuel demand
Injective (INJ) surged 10.15% after a sharp rise in derivatives activity highlighted speculative demand, with ongoing community token buybacks contributing to the attention on the protocol. The ...
  • Sergey Shendetskyi
  • 10.10.2026
Resistance test: Can Injective break out and extend gains?
Injective (INJ) is trading at $7.47, up 7.67% on the day. The price sits above its key short- and medium-term moving averages, indicating positive ...
  • Anastasiia Chabaniuk
  • 08.10.2026
Selloff pressure at $6.25 support: Can Injective avoid deeper losses?
Injective (INJ) is trading at $6.76 after falling 10.33% over the last 24 hours. The asset is currently below its short- and medium-term moving averages, but remains ...
  • Mykhailo Ihnatenko
  • 08.10.2026
What's behind Injective's latest 11.5% price pullback?
Injective (INJ) slumped 11.53% as immediate selling pressure set in following its major whitepaper overhaul and protocol update. The weakness contradicts the underlying bullish trend structure, ...
  • Parshwa Turakhiya
  • 08.10.2026
Why is Injective price down 9.9% today?
Injective (INJ) fell 9.91% after a wave of selling pressure took hold, even as recent ecosystem incentives and the announcement of a potential Staked INJ ETF aimed to foster long-term growth. The ...
  • Mira Kyivska
  • 07.10.2026
Oversold conditions: Can Injective avoid deeper losses?
Injective (INJ) is trading at $7.34, down 6.47% on the day. The token currently sits below its short- and medium-term moving averages but remains above long-term trend ...
  • Anastasiia Chabaniuk
  • 07.10.2026
Staked INJ ETF registration lifts Injective price toward $8.33 resistance
Injective (INJ) is trading at $8.17, posting a daily gain of 7.18%. The price currently sits near its session high and is positioned above its key moving averages on the ...
  • Oleg Tkachenko
  • 06.10.2026
Injective weekly outlook: Can INJ test resistance at $7.84 amid firm trend indicators?
Regulatory momentum remains in focus for Injective (INJ) as it holds near $7.59, with buyers maintaining control through a quiet week. Hopes for greater institutional ...
  • Darina Pashchenko
  • 05.10.2026
Injective expects U.S. INJ ETF launch before 2027 amid licensing push
Injective is positioning its token and institutional infrastructure for wider market access as U.S. applications tied to INJ continue moving through the regulatory process. Chief Executive Eric ...
  • Sergey Shendetskyi
  • 30.09.2026
Expanded INJ access through Solana Phantom wallet boosts Injective price toward resistance
Injective (INJ) is trading at $7.74, up 7.1% on the day. The asset is positioned above its key short- and medium-term moving averages, reflecting strong recent ...
  • Mira Kyivska
  • 29.09.2026
Injective weekly forecast: Stays rangebound as trend strength pairs with mixed short-term signals
Injective (INJ) is holding near $7.50 after slipping about 2% over the past week, as buyers keep control but momentum wanes. The recent dip reflects a pause following ...